Amin Pharmaceutical Co (XTEH:AMIN1) Market Cap: IRR0.00 Mil (As of Sep. 02, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Amin Pharmaceutical Co Market Cap?

Amin Pharmaceutical Co XTEH:AMIN1 Market Cap is IRR0.00 Mil as of Sep. 02, 2026.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Amin Pharmaceutical Co's share price for the quarter that ended in . 20 was IRR. Amin Pharmaceutical Co's Shares Outstanding (EOP) for the quarter that ended in . 20 was 0.00 Mil. Therefore, Amin Pharmaceutical Co's market cap for the quarter that ended in . 20 was IRR Mil.

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Amin Pharmaceutical Co's Enterprise Value for Today is IRR0.00 Mil.

Amin Pharmaceutical Co  (XTEH:AMIN1) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Amin Pharmaceutical Co Market Cap Related Terms

Amin Pharmaceutical Co Market Cap Historical Data

* Premium members only.

The historical data trend for Amin Pharmaceutical Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Amin Pharmaceutical Co Market Cap Chart

Amin Pharmaceutical Co Annual Data
Trend
Market Cap

Amin Pharmaceutical Co Semi-Annual Data
Market Cap

XTEH:AMIN1 vs : Market Cap Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Amin Pharmaceutical Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Amin Pharmaceutical Co Market Cap vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Amin Pharmaceutical Co's Market Cap distribution charts can be found below:

* The bar in red indicates where Amin Pharmaceutical Co's Market Cap falls into.


Amin Pharmaceutical Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Amin Pharmaceutical Co's Market Cap for the fiscal year that ended in . 20 is calculated as

Market Cap (A: . 20 )=Share Price (A: . 20 )*Shares Outstanding (EOP) (A: . 20 )
=IRR*
=IRR

Amin Pharmaceutical Co's Market Cap for the quarter that ended in . 20 is calculated as

Market Cap (Q: . 20 )=Share Price (Q: . 20 )*Shares Outstanding (EOP) (Q: . 20 )
=IRR*0
=IRR

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of IRR0.00 Mil mean?
Amin Pharmaceutical Co (XTEH:AMIN1) has a Market Cap of IRR0.00 Mil as of Sep. 02, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Amin Pharmaceutical Co and its competitors.
Is Amin Pharmaceutical Co's Market Cap too high?
Amin Pharmaceutical Co's current Market Cap is IRR0.00 Mil.
How does Amin Pharmaceutical Co's Market Cap compare to ?
Amin Pharmaceutical Co's Market Cap of IRR0.00 Mil can be compared against companies in the Drug Manufacturers industry. The industry median Market Cap is 234.62. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 234.62, based on 1,023 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Amin Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Market Cap is 234.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Amin Pharmaceutical Co's current Market Cap is IRR0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Amin Pharmaceutical Co stock overvalued right now?
Amin Pharmaceutical Co (XTEH:AMIN1) has a current Market Cap of IRR0.00 Mil. The current Market Cap is IRR0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Amin Pharmaceutical Co (XTEH:AMIN1), the current Market Cap is IRR0.00 Mil as of Sep. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Amin Pharmaceutical Co Business Description

Comparable Companies
Address Abolfazl Street, Bostan Heftam West Alley, No. 4, 2nd floor, Marzdaran, Tehran, IRN
Amin Pharmaceutical Co is engaged in the manufacturing of pharmaceutical products, chemical drugs, herbal medicines, and nutritional supplements. It offers antimicrobials, cardiovascular, antidiabetic, cerebellar, gastrointestinal, antibiotic and antifungal, and hypoglycemic agents among others. It develops drugs in the form of plain and overlaid tablets, hard, and soft capsules, oral drops, syrups, and suspensions. Products offered by the company include Acarbose, Sitagliptin, Fampridine, Ofloxacin, Amiodarone, Ibuprofen, Zolpidem, Bilberry, Thyme, and others. Amin also exports its products to Afghanistan, Kazakhstan, Uzbekistan, and Iraq.